CATHERINE MCQUISTAN: Open Payments
NPI 1619419991 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$796 in 33 payments from 19 companies in 2025. Trend: 2023 $76 · 2024 $547 · 2025 $796
Food & beverage: $796
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $165 |
| Regeneron Healthcare Solutions, Inc. | 2 | $140 |
| Amgen Inc. | 1 | $120 |
| Cleerly, Inc. | 1 | $42 |
| Novo Nordisk Inc | 2 | $35 |
| ANI Pharmaceuticals, Inc. | 2 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $32 |
| Philips North America LLC | 1 | $29 |
| Seqirus USA Inc | 1 | $29 |
| Gilead Sciences, Inc. | 1 | $21 |
Products named: EVKEEZA, REPATHA, VRAYLAR, Cleerly Ischemia, QULIPTA, Wegovy, PURIFIED CORTROPHIN GEL, Kerendia.
Industry payments across NE — which companies pay providers there.
